Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | ACR | P10323 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14884226 | 0.89 | KMT2A (0.39) | GAAKMT2AALDH1A1GBA1MAOB | |
| SCHEMBL14884288 | 0.89 | KMT2A (0.39) | GAAKMT2AALDH1A1GBA1HPGD | |
| SCHEMBL14884235 | 0.86 | KMT2A (0.37) | GAASMN1; SMN2KMT2AALDH1A1GBA1 | |
| SCHEMBL14887050 | 0.85 | MAPT (0.48) | SMN1; SMN2KMT2ALMNAPRSS1ACR | |
| SCHEMBL15248785 | 0.82 | PRSS1 (0.42) | SMN1; SMN2KMT2AMAOAMAOBLMNA | |
| SCHEMBL8903150 | 0.82 | MAOB (0.48) | GAASMN1; SMN2KMT2AALDH1A1MAOA | |
| SCHEMBL14884238 | 0.82 | KMT2A (0.34) | GAASMN1; SMN2KMT2AALDH1A1GBA1 | |
| SCHEMBL14884257 | 0.81 | TDP1 (0.50) | SMN1; SMN2KMT2AALDH1A1HPGDLMNA | |
| SCHEMBL16582498 | 0.81 | KMT2A (0.54) | GAASMN1; SMN2KMT2AALDH1A1GBA1 | |
| SCHEMBL8903862 | 0.79 | MAPT (0.46) | SMN1; SMN2KMT2AMAOAMAOBPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8722156-B2 | Liquid crystal compound and liquid crystal display | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-05-13 | — | — | US | disclosed |
| US-8722156-B2 | Liquid crystal compound and liquid crystal display | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-05-13 | — | — | US | disclosed |
| US-20130235320-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-09-12 | — | — | US | disclosed |
| US-20130235320-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-09-12 | — | — | US | disclosed |
| US-8486497-B2 | Liquid crystal compound, and liquid crystal display | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-07-16 | — | — | US | disclosed |
| US-20130100394-A1 | LIQUID CRYSTAL COMPOUND, AND LIQUID CRYSTAL DISPLAY | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130100394-A1 | LIQUID CRYSTAL COMPOUND, AND LIQUID CRYSTAL DISPLAY | CCR3, C1S, CNOT1 | GAA 4799/4885SMN1; SMN2 4837/4885KMT2A 2471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.